Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 743

1.

Cardiomyopathy in children with mitochondrial disease: Prognosis and genetic background.

Imai-Okazaki A, Kishita Y, Kohda M, Mizuno Y, Fushimi T, Matsunaga A, Yatsuka Y, Hirata T, Harashima H, Takeda A, Nakaya A, Sakata Y, Kogaki S, Ohtake A, Murayama K, Okazaki Y.

Int J Cardiol. 2019 Jan 5. pii: S0167-5273(18)34315-8. doi: 10.1016/j.ijcard.2019.01.017. [Epub ahead of print]

PMID:
30642647
2.

The successful treatment of hepatocellular carcinoma arising from congenital hepatic fibrosis using radiofrequency ablation under laparoscopy.

Hirosawa T, Morimoto N, Miura K, Ono K, Watanabe S, Fujieda T, Murayama K, Takaoka Y, Nomoto H, Tsukui M, Isoda N, Niki T, Tokushige K, Yamamoto H.

Clin J Gastroenterol. 2019 Jan 7. doi: 10.1007/s12328-018-00932-0. [Epub ahead of print]

PMID:
30617852
3.

Mitochondrial ribosomal protein PTCD3 mutations cause oxidative phosphorylation defects with Leigh syndrome.

Borna NN, Kishita Y, Kohda M, Lim SC, Shimura M, Wu Y, Mogushi K, Yatsuka Y, Harashima H, Hisatomi Y, Fushimi T, Ichimoto K, Murayama K, Ohtake A, Okazaki Y.

Neurogenetics. 2019 Jan 3. doi: 10.1007/s10048-018-0561-9. [Epub ahead of print]

PMID:
30607703
4.

Systematic Review and Meta-Analysis: Anxiety and Depressive Disorders in Offspring of Parents With Anxiety Disorders.

Lawrence PJ, Murayama K, Creswell C.

J Am Acad Child Adolesc Psychiatry. 2019 Jan;58(1):46-60. doi: 10.1016/j.jaac.2018.07.898. Epub 2018 Nov 1. Review.

5.

Early Childhood Predictors of Anxiety in Early Adolescence.

Hudson JL, Murayama K, Meteyard L, Morris T, Dodd HF.

J Abnorm Child Psychol. 2018 Dec 19. doi: 10.1007/s10802-018-0495-6. [Epub ahead of print]

PMID:
30569254
6.

Asunaprevir and daclatasvir in hemodialysis patients with chronic hepatitis C virus genotype 1b infection.

Otsuka T, Kawaguchi Y, Mizuta T, Ide Y, Koga F, Kumagai T, Yoshioka W, Murayama K, Rikitake O, Ikeda Y, Ozaki I.

JGH Open. 2017 Nov 28;1(4):148-152. doi: 10.1002/jgh3.12026. eCollection 2017 Dec.

7.

Recent topics: the diagnosis, molecular genesis, and treatment of mitochondrial diseases.

Murayama K, Shimura M, Liu Z, Okazaki Y, Ohtake A.

J Hum Genet. 2019 Feb;64(2):113-125. doi: 10.1038/s10038-018-0528-6. Epub 2018 Nov 21. Review.

PMID:
30459337
8.

My name is *** and I am a general surgeon.

Murayama KM.

Am J Surg. 2018 Nov 10. pii: S0002-9610(18)31263-7. doi: 10.1016/j.amjsurg.2018.11.001. [Epub ahead of print] No abstract available.

PMID:
30447799
9.

Prognostic impact of trisomy 21 in follicular lymphoma.

Mitsui T, Yokohama A, Koiso H, Saito A, Toyama K, Shimizu H, Ishizaki T, Irisawa H, Takizawa M, Saitoh T, Murayama K, Matsumoto M, Handa H, Hirato J, Kojima M, Murakami H, Tsukamoto N.

Br J Haematol. 2018 Nov 12. doi: 10.1111/bjh.15664. [Epub ahead of print]

PMID:
30417943
10.

Predictors of laparoscopic versus open inguinal hernia repair.

Pavlosky KK, Vossler JD, Murayama SM, Moucharite MA, Murayama KM, Mikami DJ.

Surg Endosc. 2018 Oct 29. doi: 10.1007/s00464-018-6557-6. [Epub ahead of print]

PMID:
30374789
11.

Successful control of maternal phenylketonuria by tetrahydrobiopterin.

Sakamoto O, Arai-Ichinoi N, Murayama K, Kure S.

Pediatr Int. 2018 Oct;60(10):985-986. doi: 10.1111/ped.13678. No abstract available.

PMID:
30345699
12.

No Regional Disparities in Sofosbuvir Plus Ribavirin Therapy for HCV Genotype 2 Infection in Tochigi Prefecture and its Vicinity.

Hirosawa T, Morimoto N, Miura K, Tahara T, Murohisa T, Okamura Y, Sato T, Numao N, Imai M, Tano S, Murayama K, Kurata H, Ozawa I, Fukaya Y, Yoshizumi H, Watanabe S, Tsukui M, Takaoka Y, Nomoto H, Isoda N, Yamamoto H.

Intern Med. 2018 Oct 17. doi: 10.2169/internalmedicine.1194-18. [Epub ahead of print]

13.

The relationship between seizure in electroconvulsive therapy and pupillary response using an automated pupilometer.

Shirozu K, Murayama K, Karashima Y, Setoguchi H, Miura T, Hoka S.

J Anesth. 2018 Dec;32(6):866-871. doi: 10.1007/s00540-018-2566-9. Epub 2018 Oct 16.

PMID:
30327871
14.

Reliability of diagnosing acute ischemic cerebrovascular on magnetic resonance imaging disorders using iPads.

Hattori H, Kuwayama Y, Inui Y, Murayama K, Hayakawa M, Ito S, Toyama H.

Jpn J Radiol. 2018 Dec;36(12):726-735. doi: 10.1007/s11604-018-0763-y. Epub 2018 Oct 13.

PMID:
30317411
15.

Data on substantial gravity of carbon dioxide due to pressured metered-dose inhaler steroid treatments for the 2006 year in Japan.

Murayama N, Murayama K.

Data Brief. 2018 Sep 12;20:1580-1586. doi: 10.1016/j.dib.2018.08.070. eCollection 2018 Oct.

16.

Data on nasal eosinophil positive rates in childhood asthma on each age.

Murayama N, Murayama K.

Data Brief. 2018 Sep 13;20:1573-1579. doi: 10.1016/j.dib.2018.09.018. eCollection 2018 Oct.

17.

The proportion of ocular surface diseases in untreated patients with epiphora.

Ishikawa S, Murayama K, Kato N.

Clin Ophthalmol. 2018 Sep 11;12:1769-1773. doi: 10.2147/OPTH.S172503. eCollection 2018.

18.

The role of interest in memory for trivia questions: An investigation with a large-scale database.

Fastrich GM, Kerr T, Castel AD, Murayama K.

Motiv Sci. 2018 Sep;4(3):227-250. doi: 10.1037/mot0000087. Epub 2017 Dec 18.

PMID:
30221181
19.

Structural Basis for the Inhibition of Cyclin G-Associated Kinase by Gefitinib.

Ohbayashi N, Murayama K, Kato-Murayama M, Kukimoto-Niino M, Uejima T, Matsuda T, Ohsawa N, Yokoyoma S, Nojima H, Shirouzu M.

ChemistryOpen. 2018 Sep 10;7(9):721-727. doi: 10.1002/open.201800177. eCollection 2018 Sep.

20.

Mitochondrial DNA 3243A>T mutation in a patient with MELAS syndrome.

Ikeda T, Osaka H, Shimbo H, Tajika M, Yamazaki M, Ueda A, Murayama K, Yamagata T.

Hum Genome Var. 2018 Sep 4;5:25. doi: 10.1038/s41439-018-0026-6. eCollection 2018.

21.

Correction: Effectiveness of plasma lyso-Gb3 as a biomarker for selecting high-risk patients with Fabry disease from multispecialty clinics for genetic analysis.

Maruyama H, Miyata K, Mikame M, Taguchi A, Guili C, Shimura M, Murayama K, Inoue T, Yamamoto S, Sugimura K, Tamita K, Kawasaki T, Kajihara J, Onishi A, Sugiyama H, Sakai T, Murata I, Oda T, Toyoda S, Hanawa K, Fujimura T, Ura S, Matsumura M, Takano H, Yamashita S, Matsukura G, Tazawa R, Shiga T, Ebato M, Satoh H, Ishii S.

Genet Med. 2018 Sep 12. doi: 10.1038/s41436-018-0258-3. [Epub ahead of print]

PMID:
30209272
22.

Mutations in TOP3A Cause a Bloom Syndrome-like Disorder.

Martin CA, Sarlós K, Logan CV, Thakur RS, Parry DA, Bizard AH, Leitch A, Cleal L, Ali NS, Al-Owain MA, Allen W, Altmüller J, Aza-Carmona M, Barakat BAY, Barraza-García J, Begtrup A, Bogliolo M, Cho MT, Cruz-Rojo J, Dhahrabi HAM, Elcioglu NH; GOSgene, Gorman GS, Jobling R, Kesterton I, Kishita Y, Kohda M, Le Quesne Stabej P, Malallah AJ, Nürnberg P, Ohtake A, Okazaki Y, Pujol R, Ramirez MJ, Revah-Politi A, Shimura M, Stevens P, Taylor RW, Turner L, Williams H, Wilson C, Yigit G, Zahavich L, Alkuraya FS, Surralles J, Iglesias A, Murayama K, Wollnik B, Dattani M, Heath KE, Hickson ID, Jackson AP.

Am J Hum Genet. 2018 Sep 6;103(3):456. doi: 10.1016/j.ajhg.2018.08.012. No abstract available.

23.

Correction: Effectiveness of plasma lyso-Gb3 as a biomarker for selecting high-risk patients with Fabry disease from multispecialty clinics for genetic analysis.

Maruyama H, Miyata K, Mikame M, Taguchi A, Guili C, Shimura M, Murayama K, Inoue T, Yamamoto S, Sugimura K, Tamita K, Kawasaki T, Kajihara J, Onishi A, Sugiyama H, Sakai T, Murata I, Oda T, Toyoda S, Hanawa K, Fujimura T, Ura S, Matsumura M, Takano H, Yamashita S, Matsukura G, Tazawa R, Shiga T, Ebato M, Satoh H, Ishii S.

Genet Med. 2018 Sep 7. doi: 10.1038/s41436-018-0125-2. [Epub ahead of print]

PMID:
30190610
24.

FEAT enhances INSL3 expression in testicular Leydig cells.

Li Y, Kobayashi K, Murayama K, Kawahara K, Shima Y, Suzuki A, Tani K, Takahashi A.

Genes Cells. 2018 Nov;23(11):952-962. doi: 10.1111/gtc.12644. Epub 2018 Oct 2.

PMID:
30178547
25.

The Effect of Concomitant Arthroscopic Lateral Retinacular Release on Postoperative Patellar Position and Orientation in Open Wedge High Tibial Osteotomy.

Murayama K, Nakayama H, Murakami T, Yoshiya S, Otsuki S, Tachibana T.

Knee Surg Relat Res. 2018 Sep 1;30(3):241-246. doi: 10.5792/ksrr.18.006.

26.

Late-onset ornithine transcarbamylase deficiency caused by a somatic mosaic mutation.

Lee T, Misaki M, Shimomura H, Tanaka Y, Yoshida S, Murayama K, Nakamura K, Fujiki R, Ohara O, Sasai H, Fukao T, Takeshima Y.

Hum Genome Var. 2018 Aug 16;5:22. doi: 10.1038/s41439-018-0022-x. eCollection 2018.

27.

Mutations in TOP3A Cause a Bloom Syndrome-like Disorder.

Martin CA, Sarlós K, Logan CV, Thakur RS, Parry DA, Bizard AH, Leitch A, Cleal L, Ali NS, Al-Owain MA, Allen W, Altmüller J, Aza-Carmona M, Barakat BAY, Barraza-García J, Begtrup A, Bogliolo M, Cho MT, Cruz-Rojo J, Dhahrabi HAM, Elcioglu NH; GOSgene, Gorman GS, Jobling R, Kesterton I, Kishita Y, Kohda M, Le Quesne Stabej P, Malallah AJ, Nürnberg P, Ohtake A, Okazaki Y, Pujol R, Ramirez MJ, Revah-Politi A, Shimura M, Stevens P, Taylor RW, Turner L, Williams H, Wilson C, Yigit G, Zahavich L, Alkuraya FS, Surralles J, Iglesias A, Murayama K, Wollnik B, Dattani M, Heath KE, Hickson ID, Jackson AP.

Am J Hum Genet. 2018 Aug 2;103(2):221-231. doi: 10.1016/j.ajhg.2018.07.001. Epub 2018 Jul 26. Erratum in: Am J Hum Genet. 2018 Sep 6;103(3):456.

28.

A unique increase in prefrontal gray matter volume in hoarding disorder compared to obsessive-compulsive disorder.

Yamada S, Nakao T, Ikari K, Kuwano M, Murayama K, Tomiyama H, Hasuzawa S, Togao O, Hiwatashi A, Kanba S.

PLoS One. 2018 Jul 16;13(7):e0200814. doi: 10.1371/journal.pone.0200814. eCollection 2018.

29.

Response to "infantile-onset deafness in m.7445A>G carriers may be multicausal".

Matsunaga T, Matsushima K, Murayama K.

Int J Pediatr Otorhinolaryngol. 2018 Aug;111:194. doi: 10.1016/j.ijporl.2018.06.023. Epub 2018 Jun 14. No abstract available.

PMID:
29934116
30.

Neural Correlates for Intrinsic Motivational Deficits of Schizophrenia; Implications for Therapeutics of Cognitive Impairment.

Takeda K, Sumiyoshi T, Matsumoto M, Murayama K, Ikezawa S, Matsumoto K, Nakagome K.

Front Psychiatry. 2018 Jun 5;9:178. doi: 10.3389/fpsyt.2018.00178. eCollection 2018. Review.

31.

A successful treatment for hepatocellular carcinoma with Osler-Rendu-Weber disease using radiofrequency ablation under laparoscopy.

Takaoka Y, Morimoto N, Miura K, Nomoto H, Murayama K, Hirosawa T, Watanabe S, Fujieda T, Ttsukui M, Kawata H, Niki T, Isoda N, Iijima M, Yamamoto H.

Clin J Gastroenterol. 2018 Jun 16. doi: 10.1007/s12328-018-0877-x. [Epub ahead of print]

PMID:
29909559
32.

Data on various allergen specific IgEs and prospective treatments on food-dependent exercise-induced anaphylaxis.

Murayama N, Murayama K.

Data Brief. 2018 May 5;18:1895-1899. doi: 10.1016/j.dib.2018.04.097. eCollection 2018 Jun.

33.

The Ventral Anterior Temporal Lobe has a Necessary Role in Exception Word Reading.

Ueno T, Meteyard L, Hoffman P, Murayama K.

Cereb Cortex. 2018 Aug 1;28(8):3035-3045. doi: 10.1093/cercor/bhy131.

34.

Nonerosive reflux disease: clinical concepts.

Gyawali CP, Azagury DE, Chan WW, Chandramohan SM, Clarke JO, de Bortoli N, Figueredo E, Fox M, Jodorkovsky D, Lazarescu A, Malfertheiner P, Martinek J, Murayama KM, Penagini R, Savarino E, Shetler KP, Stein E, Tatum RP, Wu J.

Ann N Y Acad Sci. 2018 Dec;1434(1):290-303. doi: 10.1111/nyas.13845. Epub 2018 May 15. Review.

PMID:
29761528
35.

Comparison of the Clinical Efficacy of Salbutamol with Jet and Mesh Nebulizers in Asthmatic Children.

Murayama N, Murayama K.

Pulm Med. 2018 Mar 13;2018:1648652. doi: 10.1155/2018/1648652. eCollection 2018.

36.

Mutations in COA7 cause spinocerebellar ataxia with axonal neuropathy.

Higuchi Y, Okunushi R, Hara T, Hashiguchi A, Yuan J, Yoshimura A, Murayama K, Ohtake A, Ando M, Hiramatsu Y, Ishihara S, Tanabe H, Okamoto Y, Matsuura E, Ueda T, Toda T, Yamashita S, Yamada K, Koide T, Yaguchi H, Mitsui J, Ishiura H, Yoshimura J, Doi K, Morishita S, Sato K, Nakagawa M, Yamaguchi M, Tsuji S, Takashima H.

Brain. 2018 Jun 1;141(6):1622-1636. doi: 10.1093/brain/awy104.

37.

High-level heteroplasmy for the m.7445A>G mitochondrial DNA mutation can cause progressive sensorineural hearing loss in infancy.

Matsushima K, Nakano A, Arimoto Y, Mutai H, Yamazawa K, Murayama K, Matsunaga T.

Int J Pediatr Otorhinolaryngol. 2018 May;108:125-131. doi: 10.1016/j.ijporl.2018.02.037. Epub 2018 Feb 27.

PMID:
29605341
38.

Bortezomib maintenance therapy in transplant-ineligible myeloma patients who plateaued after bortezomib-based induction therapy: a multicenter phase II clinical trial.

Isoda A, Murayama K, Ito S, Kohara Y, Iino M, Miyazawa Y, Matsumoto M, Handa H, Imai Y, Ishiguro T, Izumita W, Kitano K, Hirabayashi Y, Nakazawa H, Ishida F, Mitsumori T, Kirito K, Chou T, Murakami H; Kanshinetsu Multiple Myeloma Study Group.

Int J Hematol. 2018 Jul;108(1):39-46. doi: 10.1007/s12185-018-2448-9. Epub 2018 Mar 28.

PMID:
29594921
39.

Curiosity in old age: A possible key to achieving adaptive aging.

Sakaki M, Yagi A, Murayama K.

Neurosci Biobehav Rev. 2018 May;88:106-116. doi: 10.1016/j.neubiorev.2018.03.007. Epub 2018 Mar 12. Review.

PMID:
29545165
40.

Effectiveness of plasma lyso-Gb3 as a biomarker for selecting high-risk patients with Fabry disease from multispecialty clinics for genetic analysis.

Maruyama H, Miyata K, Mikame M, Taguchi A, Guili C, Shimura M, Murayama K, Inoue T, Yamamoto S, Sugimura K, Tamita K, Kawasaki T, Kajihara J, Onishi A, Sugiyama H, Sakai T, Murata I, Oda T, Toyoda S, Hanawa K, Fujimura T, Ura S, Matsumura M, Takano H, Yamashita S, Matsukura G, Tazawa R, Shiga T, Ebato M, Satoh H, Ishii S.

Genet Med. 2019 Jan;21(1):44-52. doi: 10.1038/gim.2018.31. Epub 2018 Mar 15. Erratum in: Genet Med. 2018 Sep 7;:. Genet Med. 2018 Sep 12;:.

PMID:
29543226
41.

Leigh syndrome with spinal cord involvement due to a hemizygous NDUFA1 mutation.

Miyauchi A, Osaka H, Nagashima M, Kuwajima M, Monden Y, Kohda M, Kishita Y, Okazaki Y, Murayama K, Ohtake A, Yamagata T.

Brain Dev. 2018 Jun;40(6):498-502. doi: 10.1016/j.braindev.2018.02.007. Epub 2018 Mar 3.

PMID:
29506883
42.

MT-ND5 Mutation Exhibits Highly Variable Neurological Manifestations at Low Mutant Load.

Ng YS, Lax NZ, Maddison P, Alston CL, Blakely EL, Hepplewhite PD, Riordan G, Meldau S, Chinnery PF, Pierre G, Chronopoulou E, Du A, Hughes I, Morris AA, Kamakari S, Chrousos G, Rodenburg RJ, Saris CGJ, Feeney C, Hardy SA, Sakakibara T, Sudo A, Okazaki Y, Murayama K, Mundy H, Hanna MG, Ohtake A, Schaefer AM, Champion MP, Turnbull DM, Taylor RW, Pitceathly RDS, McFarland R, Gorman GS.

EBioMedicine. 2018 Apr;30:86-93. doi: 10.1016/j.ebiom.2018.02.010. Epub 2018 Feb 24.

43.

An infant case of diffuse cerebrospinal lesions and cardiomyopathy caused by a BOLA3 mutation.

Nishioka M, Inaba Y, Motobayashi M, Hara Y, Numata R, Amano Y, Shingu K, Yamamoto Y, Murayama K, Ohtake A, Nakazawa Y.

Brain Dev. 2018 Jun;40(6):484-488. doi: 10.1016/j.braindev.2018.02.004. Epub 2018 Mar 2.

PMID:
29501406
44.

Preliminary study of time maximum intensity projection computed tomography imaging for the detection of early ischemic change in patient with acute ischemic stroke.

Murayama K, Suzuki S, Matsukiyo R, Takenaka A, Hayakawa M, Tsutsumi T, Fujii K, Katada K, Toyama H.

Medicine (Baltimore). 2018 Mar;97(9):e9906. doi: 10.1097/MD.0000000000009906.

45.

Mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes with severe systemic symptoms: Pathology and biochemistry.

Kondo H, Fujita Y, Mizuno Y, Kihara M, Murayama K.

Pediatr Int. 2018 Mar;60(3):300-302. doi: 10.1111/ped.13472. Epub 2018 Feb 26. No abstract available.

PMID:
29480536
46.

Clinical management and outcomes of completely resected stage I follicular lymphoma.

Yokohama A, Hashimoto Y, Takizawa M, Shimizu H, Miyazawa Y, Saitoh A, Toyama K, Ishizaki T, Mitsui T; Hiromi; Koiso, Saitoh T, Murayama K, Matsumoto M, Sawamura M, Murakami H, Hirato J, Kojima M, Nojima Y, Handa H, Tsukamoto N.

J Clin Exp Hematop. 2018 Mar 16;58(1):10-16. doi: 10.3960/jslrt.17031. Epub 2018 Feb 8.

47.

Metabolic and chemical regulation of tRNA modification associated with taurine deficiency and human disease.

Asano K, Suzuki T, Saito A, Wei FY, Ikeuchi Y, Numata T, Tanaka R, Yamane Y, Yamamoto T, Goto T, Kishita Y, Murayama K, Ohtake A, Okazaki Y, Tomizawa K, Sakaguchi Y, Suzuki T.

Nucleic Acids Res. 2018 Feb 28;46(4):1565-1583. doi: 10.1093/nar/gky068.

48.

Do clinically anxious children cluster according to their expression of factors that maintain child anxiety?

Pearcey S, Alkozei A, Chakrabarti B, Dodd H, Murayama K, Stuijfzand S, Creswell C.

J Affect Disord. 2018 Mar 15;229:469-476. doi: 10.1016/j.jad.2017.12.078. Epub 2018 Jan 3.

49.

Loss of the Mitochondrial Fatty Acid β-Oxidation Protein Medium-Chain Acyl-Coenzyme A Dehydrogenase Disrupts Oxidative Phosphorylation Protein Complex Stability and Function.

Lim SC, Tajika M, Shimura M, Carey KT, Stroud DA, Murayama K, Ohtake A, McKenzie M.

Sci Rep. 2018 Jan 9;8(1):153. doi: 10.1038/s41598-017-18530-4.

50.

MPV17-related mitochondrial DNA maintenance defect: New cases and review of clinical, biochemical, and molecular aspects.

El-Hattab AW, Wang J, Dai H, Almannai M, Staufner C, Alfadhel M, Gambello MJ, Prasun P, Raza S, Lyons HJ, Afqi M, Saleh MAM, Faqeih EA, Alzaidan HI, Alshenqiti A, Flore LA, Hertecant J, Sacharow S, Barbouth DS, Murayama K, Shah AA, Lin HC, Wong LC.

Hum Mutat. 2018 Apr;39(4):461-470. doi: 10.1002/humu.23387. Epub 2018 Jan 13.

PMID:
29282788

Supplemental Content

Loading ...
Support Center